Brief: China NT Pharma enters deal to issue 325 mln shares at HK$1.83 per share
19/04/2017 13:44
April 19 (Reuters) - China NT Pharma Group Co Ltd 1011.HK
* Company entered into placing agreement
* Co agreed to issue aggregate of 325 million convertible
preference shares at a price of HK$1.83 per convertible
preference shares
Source text (http://bit.ly/2pRmc0t)
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY